메뉴 건너뛰기




Volumn 26, Issue 4, 2009, Pages 447-454

Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones

Author keywords

Gatifloxacin ophthalmic solution 0.3 ; Moxifloxacin ophthalmic solution 0.5 ; Ocular surgery prophylaxis; Speed of bactericidal activity

Indexed keywords

EYE DROPS; GATIFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

EID: 73449148742     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0018-5     Document Type: Article
Times cited : (21)

References (33)
  • 1
    • 20444480579 scopus 로고    scopus 로고
    • Acute-onset endophthalmitis after cataract surgery (2000-2004): Incidence, clinical settings, and visual acuity outcomes after treatment
    • 15953426 10.1016/j.ajo.2005.01.011
    • J.J. Miller I.U. Scott H.W. Flynn Jr. W.E. Smiddy J. Newton D. Miller 2005 Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment Am J Ophthalmol 139 983 987 15953426 10.1016/j.ajo.2005.01.011
    • (2005) Am J Ophthalmol , vol.139 , pp. 983-987
    • Miller, J.J.1    Scott, I.U.2    Flynn, Jr.H.W.3    Smiddy, W.E.4    Newton, J.5    Miller, D.6
  • 4
    • 0025875354 scopus 로고
    • Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis
    • 2062496 1:STN:280:DyaK3M3osl2qtw%3D%3D
    • M.G. Speaker F.A. Milch M.K. Shah W. Eisner B.N. Kreiswirth 1991 Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis Ophthalmology 98 639 649 2062496 1:STN:280:DyaK3M3osl2qtw%3D%3D
    • (1991) Ophthalmology , vol.98 , pp. 639-649
    • Speaker, M.G.1    Milch, F.A.2    Shah, M.K.3    Eisner, W.4    Kreiswirth, B.N.5
  • 5
    • 0035150945 scopus 로고    scopus 로고
    • Use of antimicrobials to prevent postoperative infection in patients with cataracts
    • DOI 10.1097/00055735-200102000-00012
    • T.J. Liesegang 2001 Use of antimicrobials to prevent postoperative infection in patients with cataracts Curr Opin Ophthalmol 12 68 74 11150084 10.1097/00055735-200102000-00012 1:STN:280:DC%2BD3M7hvFejtA%3D%3D (Pubitemid 32113615)
    • (2001) Current Opinion in Ophthalmology , vol.12 , Issue.1 , pp. 68-74
    • Liesegang, T.J.1
  • 6
    • 0242416974 scopus 로고    scopus 로고
    • Infectious keratitis after photorefractive keratectomy
    • DOI 10.1016/S0161-6420(02)01936-X
    • E.D. Donnenfeld T.P. O'Brien R. Solomon H.D. Perry M.G. Speaker J. Wittpenn 2003 Infectious keratitis after photorefractive keratectomy Ophthalmology 110 743 747 12689896 10.1016/S0161-6420(02)01936-X (Pubitemid 36520073)
    • (2003) Ophthalmology , vol.110 , Issue.4 , pp. 743-747
    • Donnenfeld, E.D.1    O'Brien, T.P.2    Solomon, R.3    Perry, H.D.4    Speaker, M.G.5    Wittpenn, J.6
  • 7
    • 27844600344 scopus 로고    scopus 로고
    • Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®)
    • DOI 10.1016/j.survophthal.2005.05.005, PII S003962570500055X
    • B.A. Schlech J. Blondeau 2005 Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) Surv Ophthalmol 50 suppl.1 S64 S67 16257312 10.1016/j.survophthal.2005.05.005 (Pubitemid 41657600)
    • (2005) Survey of Ophthalmology , vol.50 , Issue.6 SUPPL. 1
    • Schlech, B.A.1    Blondeau, J.2
  • 8
    • 0347763439 scopus 로고    scopus 로고
    • Antibacterial activity of the fourthgeneration fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens
    • 14964344 10.1007/BF02849853 1:CAS:528:DC%2BD2cXht1ekt7Y%3D
    • M.C. Callegan R. Ramirez S.T. Kane D.C. Cochran H. Jensen 2003 Antibacterial activity of the fourthgeneration fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens Adv Ther 20 246 252 14964344 10.1007/BF02849853 1:CAS:528:DC%2BD2cXht1ekt7Y%3D
    • (2003) Adv Ther , vol.20 , pp. 246-252
    • Callegan, M.C.1    Ramirez, R.2    Kane, S.T.3    Cochran, D.C.4    Jensen, H.5
  • 9
    • 14644444121 scopus 로고    scopus 로고
    • Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor
    • DOI 10.1016/j.ophtha.2004.09.029
    • R. Solomon E.D. Donnenfeld H.D. Perry 2005 Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor Ophthalmology 112 466 469 15745775 10.1016/j.ophtha.2004.09.029 (Pubitemid 40312502)
    • (2005) Ophthalmology , vol.112 , Issue.3 , pp. 466-469
    • Solomon, R.1    Donnenfeld, E.D.2    Perry, H.D.3    Snyder, R.W.4    Nedrud, C.5    Stein, J.6    Bloom, A.7
  • 10
    • 0042828942 scopus 로고    scopus 로고
    • Gatifloxacin and moxifloxacin: An in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates
    • DOI 10.1016/S0002-9394(03)00294-0
    • R.P. Kowalski D.K. Dhaliwal L.M. Karenchak 2003 Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates Am J Ophthalmol 136 500 505 12967804 10.1016/S0002-9394(03)00294-0 1:CAS:528: DC%2BD3sXntVKitLw%3D (Pubitemid 37101247)
    • (2003) American Journal of Ophthalmology , vol.136 , Issue.3 , pp. 500-505
    • Kowalski, R.P.1    Dhaliwal, D.K.2    Karenchak, L.M.3    Romanowski, E.G.4    Mah, F.S.5    Ritterband, D.C.6    Gordon, Y.J.7
  • 11
    • 73449138665 scopus 로고    scopus 로고
    • [package insert]. Irvine, CA: Allergan, Inc.
    • Zymar® [package insert]. Irvine, CA: Allergan, Inc.; 2007.
    • (2007) Zymar®
  • 12
    • 73449133644 scopus 로고    scopus 로고
    • [package insert]. Fort Worth, TX: Alcon Laboratories, Inc.
    • Vigamox® [package insert]. Fort Worth, TX: Alcon Laboratories, Inc.; 2006.
    • (2006) Vigamox®
  • 13
    • 34247869622 scopus 로고    scopus 로고
    • Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus
    • 17434822 1:CAS:528:DC%2BD2sXlsVWhsbY%3D
    • J.M. Blondeau S. Borsos C.K. Hesje 2007 Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus J Chemother 19 146 151 17434822 1:CAS:528:DC%2BD2sXlsVWhsbY%3D
    • (2007) J Chemother , vol.19 , pp. 146-151
    • Blondeau, J.M.1    Borsos, S.2    Hesje, C.K.3
  • 14
    • 48349127444 scopus 로고    scopus 로고
    • Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis
    • 18665809 10.1089/jop.2008.0017 1:CAS:528:DC%2BD1cXptFCgs7w%3D
    • E.G. Romanowski F.S. Mah R.P. Kowalski K.A. Yates Y.J. Gordon 2008 Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis J Ocul Pharmacol Ther 24 380 384 18665809 10.1089/jop.2008.0017 1:CAS:528:DC%2BD1cXptFCgs7w%3D
    • (2008) J Ocul Pharmacol Ther , vol.24 , pp. 380-384
    • Romanowski, E.G.1    Mah, F.S.2    Kowalski, R.P.3    Yates, K.A.4    Gordon, Y.J.5
  • 15
    • 26844549599 scopus 로고    scopus 로고
    • Inflow of ocular surface fluid into the anterior chamber after phacoemulsification through sutureless corneal cataract wounds
    • DOI 10.1016/j.ajo.2005.03.069, PII S0002939405004204
    • S. Herretes W.J. Stark A. Pirouzmanesh J.M. Reyes P.J. McDonnell A. Behrens 2005 Inflow of ocular surface fluid into the anterior chamber after phacoemulsification through sutureless corneal cataract wounds Am J Ophthalmol 140 737 740 16226532 10.1016/j.ajo.2005.03.069 (Pubitemid 41455325)
    • (2005) American Journal of Ophthalmology , vol.140 , Issue.4 , pp. 737-740
    • Herretes, S.1    Stark, W.J.2    Pirouzmanesh, A.3    Reyes, J.M.G.4    McDonnell, P.J.5    Behrens, A.6
  • 17
    • 32044465755 scopus 로고    scopus 로고
    • Fluorescent amplified fragment length polymorphism (FAFLP) genotyping demonstrates the role of biofilm-producing methicillin-resistant periocular Staphylococcus epidermidis strains in postoperative endophthalmitis
    • DOI 10.1186/1471-2415-6-1
    • P. Kenchappa A. Duggirala N. Ahmed 2006 Fluorescent amplified fragment length polymorphism (FAFLP) genotyping demonstrates the role of biofilm-producing methicillin-resistant periocular Staphylococcus epidermidis strains in postoperative endophthalmitis BMC Ophthalmol 6 1 5 16396685 10.1186/1471-2415-6-1 (Pubitemid 43197350)
    • (2006) BMC Ophthalmology , vol.6 , pp. 1
    • Kenchappa, P.1    Duggirala, A.2    Ahmed, N.3    Pathengay, A.4    Das, T.5    Hasnain, S.E.6    Sharma, S.7
  • 18
    • 1342305310 scopus 로고    scopus 로고
    • Pharmacologic considerations for cataract surgery
    • DOI 10.1097/00055735-200402000-00010
    • R. Tipperman 2004 Pharmacologic considerations for cataract surgery Curr Opin Ophthalmol 15 51 55 14743020 10.1097/00055735-200402000-00010 (Pubitemid 38265191)
    • (2004) Current Opinion in Ophthalmology , vol.15 , Issue.1 , pp. 51-55
    • Tipperman, R.1
  • 19
    • 33750968802 scopus 로고    scopus 로고
    • The In vitro Impact of Moxifloxacin and Gatifloxacin Concentration (0.5% vs 0.3%) and the Addition of Benzalkonium Chloride on Antibacterial Efficacy
    • DOI 10.1016/j.ajo.2006.06.006, PII S0002939406006945
    • R.P. Kowalski B.R. Kowalski E.G. Romanowski F.S. Mah P.P. Thompson Y.J. Gordon 2006 The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy Am J Ophthalmol 142 730 735 16978577 10.1016/j.ajo.2006.06.006 1:CAS:528:DC%2BD28XhtFSnurrE (Pubitemid 44739921)
    • (2006) American Journal of Ophthalmology , vol.142 , Issue.5
    • Kowalski, R.P.1    Kowalski, B.R.2    Romanowski, E.G.3    Mah, F.S.4    Thompson, P.P.5    Gordon, Y.J.6
  • 20
    • 18144431291 scopus 로고    scopus 로고
    • The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar® (gatifloxacin 0.3%) in a NZW rabbit model
    • DOI 10.1016/j.ajo.2005.01.021
    • E.G. Romanowski F.S. Mah K.A. Yates R.P. Kowalski Y.J. Gordon 2005 The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model Am J Ophthalmol 139 867 877 15860293 10.1016/j.ajo.2005.01.021 1:CAS:528:DC%2BD2MXjslKnsLk%3D (Pubitemid 40614774)
    • (2005) American Journal of Ophthalmology , vol.139 , Issue.5 , pp. 867-877
    • Romanowski, E.G.1    Mah, F.S.2    Yates, K.A.3    Kowalski, R.P.4    Gordon, Y.J.5
  • 21
    • 0038016404 scopus 로고    scopus 로고
    • Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model
    • DOI 10.1016/S0002-9394(02)02280-8
    • T. Tungsiripat M.A. Sarayba M.B. Kaufman 2003 Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model Am J Ophthalmol 136 76 81 12834673 10.1016/S0002-9394(02)02280-8 1:CAS:528:DC%2BD3sXkvFKlsbc%3D (Pubitemid 36794498)
    • (2003) American Journal of Ophthalmology , vol.136 , Issue.1 , pp. 76-81
    • Tungsiripat, T.1    Sarayba, M.A.2    Kaufman, M.B.3    Sweet, P.M.4    Taban, M.5    Carpenter, T.R.6    McDonnell, P.J.7
  • 22
    • 0033511289 scopus 로고    scopus 로고
    • Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review
    • 10406613 1:STN:280:DyaK1Mzjtlaksw%3D%3D
    • M.H. Goldstein R.P. Kowalski Y.J. Gordon 1999 Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review Ophthalmology 106 1313 1318 10406613 1:STN:280:DyaK1Mzjtlaksw%3D%3D
    • (1999) Ophthalmology , vol.106 , pp. 1313-1318
    • Goldstein, M.H.1    Kowalski, R.P.2    Gordon, Y.J.3
  • 23
    • 0036206726 scopus 로고    scopus 로고
    • Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics
    • DOI 10.1016/S0002-9394(02)01334-X, PII S000293940201334X
    • R. Mather L.M. Karenchak E.G. Romanowski R.P. Kowalski 2002 Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics Am J Ophthalmol 133 463 466 11931779 10.1016/S0002-9394(02)01334-X 1:CAS:528:DC%2BD38XisV2rtLw%3D (Pubitemid 34258055)
    • (2002) American Journal of Ophthalmology , vol.133 , Issue.4 , pp. 463-466
    • Mather, R.1    Karenchak, L.M.2    Romanowski, E.G.3    Kowalski, R.P.4
  • 24
    • 0034454247 scopus 로고    scopus 로고
    • Mechanisms of action and resistance of older and newer fluoroquinolones
    • DOI 10.1086/314056
    • D.C. Hooper 2000 Mechanisms of action and resistance of older and newer fluoroquinolones Clin Infect Dis 31 suppl.2 S24 S28 10984324 10.1086/314056 1:CAS:528:DC%2BD3cXnsVelsrs%3D (Pubitemid 32269605)
    • (2000) Clinical Infectious Diseases , vol.31 , Issue.SUPPL. 2
    • Hooper, D.C.1
  • 25
    • 33646009199 scopus 로고    scopus 로고
    • Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones
    • 16527462 10.1016/j.ijantimicag.2005.10.022 1:CAS:528:DC%2BD28Xjs1yiurc%3D
    • L. Huelves D. Sevillano C. Martinez-Marin 2006 Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones Int J Antimicrob Agents 27 294 299 16527462 10.1016/j.ijantimicag.2005.10.022 1:CAS:528:DC%2BD28Xjs1yiurc%3D
    • (2006) Int J Antimicrob Agents , vol.27 , pp. 294-299
    • Huelves, L.1    Sevillano, D.2    Martinez-Marin, C.3
  • 26
    • 0029824413 scopus 로고    scopus 로고
    • Quinolone resistance mutations in topoisomerase IV: Relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus
    • 8843298 1:CAS:528:DyaK28Xks12quro%3D
    • E.Y. Ng M. Trucksis D.C. Hooper 1996 Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus Antimicrob Agents Chemother 40 1881 1888 8843298 1:CAS:528:DyaK28Xks12quro%3D
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 1881-1888
    • Ng, E.Y.1    Trucksis, M.2    Hooper, D.C.3
  • 27
    • 0036146667 scopus 로고    scopus 로고
    • Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones
    • DOI 10.1128/AAC.46.2.413-419.2002
    • G. Yague J.E. Morris X.S. Pan K.A. Gould L.M. Fisher 2002 Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones Antimicrob Agents Chemother 46 413 419 11796351 10.1128/AAC.46.2.413-419.2002 1:CAS:528:DC%2BD38XosFyitA%3D%3D (Pubitemid 34087189)
    • (2002) Antimicrobial Agents and Chemotherapy , vol.46 , Issue.2 , pp. 413-419
    • Yague, G.1    Morris, J.E.2    Pan, X.-S.3    Gould, K.A.4    Fisher, L.M.5
  • 28
    • 1542708136 scopus 로고    scopus 로고
    • Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones
    • DOI 10.1016/j.survophthal.2004.01.004, PII S0039625704000050
    • D.G. Hwang 2004 Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones Surv Ophthalmol 49 suppl.2 S79 S83 15028483 10.1016/j.survophthal.2004.01.004 (Pubitemid 38353039)
    • (2004) Survey of Ophthalmology , vol.49 , Issue.2 SUPPL. 2
    • Hwang, D.G.1
  • 30
    • 54949108951 scopus 로고    scopus 로고
    • Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora
    • 18708260 10.1016/j.ophtha.2008.06.024
    • J.M. Moss D. Nguyen Y.I. Liu 2008 Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora Ophthalmology 115 2013 2016 18708260 10.1016/j.ophtha.2008.06.024
    • (2008) Ophthalmology , vol.115 , pp. 2013-2016
    • Moss, J.M.1    Nguyen, D.2    Liu, Y.I.3
  • 31
    • 48349099560 scopus 로고    scopus 로고
    • Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a oneday or one-hour application
    • 18665815 10.1089/jop.2008.0018 1:CAS:528:DC%2BD1cXptFCgs78%3D
    • C.N. Ta I. Chan H.S. Dhatt 2008 Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a oneday or one-hour application J Ocul Pharmacol Ther 24 427 431 18665815 10.1089/jop.2008.0018 1:CAS:528:DC%2BD1cXptFCgs78%3D
    • (2008) J Ocul Pharmacol Ther , vol.24 , pp. 427-431
    • Ta, C.N.1    Chan, I.2    Dhatt, H.S.3
  • 32
    • 49649102957 scopus 로고    scopus 로고
    • Third- and fourth-generation fluoroquinolones: Retrospective comparison of endophthalmitis after cataract surgery performed over 10 years
    • 18721704 10.1016/j.jcrs.2008.05.045
    • M.K. Jensen R.G. Fiscella M. Moshirfar B. Mooney 2008 Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years J Cataract Refract Surg 34 1460 1467 18721704 10.1016/j.jcrs.2008.05.045
    • (2008) J Cataract Refract Surg , vol.34 , pp. 1460-1467
    • Jensen, M.K.1    Fiscella, R.G.2    Moshirfar, M.3    Mooney, B.4
  • 33
    • 33947601439 scopus 로고    scopus 로고
    • Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones. A retrospective observational case series
    • DOI 10.1016/j.ophtha.2006.08.038, PII S0161642006012085
    • M. Moshirfar V. Feiz A.T. Vitale J.A. Wegelin S. Basavanthappa D.H. Wolsey 2007 Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series Ophthalmology 114 686 691 17184840 10.1016/j.ophtha.2006.08.038 (Pubitemid 46483686)
    • (2007) Ophthalmology , vol.114 , Issue.4 , pp. 686-691
    • Moshirfar, M.1    Feiz, V.2    Vitale, A.T.3    Wegelin, J.A.4    Basavanthappa, S.5    Wolsey, D.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.